Monday, April 25, 2016

U.S. FDA panel meets to discuss Sarepta muscular dystrophy drug

April 25 (Reuters) - Hundreds of patients and advocates

packed a hotel ballroom in Hyattsville, Maryland on Monday to

try to persuade advisors to the U.S. Food and Drug

Administration to support...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)